Boada M, Lpez OL, Olazarn J, et al
Infliximab Infliximab, the mouse-human chimeric anti-TNF monoclonal antibody, was approved by the FDA for the treatment of PsA based on two pivotal trials known as the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) and IMPACT 2
They stopped looking the other way
McIntyre RS, Rasgon N, Goldberg J, Wong S, Le GH, Mansur RB, Rosenblat JD, Teopiz KM, Stahl SM (2025) The effect of glucagon-like peptide-1 and glucose dependent insulinotropic polypeptide receptor agonists on neurogenesis, differentiation, and plasticity (Neuro-GDP): potential mechanistically informed therapeutics in the treatment and prevention of mental disorders
Chronic inflammation affects millions of people and can show up in surprising ways, from joint pain and digestive troubles to long COVID symptoms and autoimmune flares
Your PA can be valid for anywhere between 30 days and over a year, depending on your coverage